Dosage, Storage, and Handling for Pixclara® (18F-FET)
Actor portrayal
Dosage and administration1
Recommended dosage in adult patients
The recommended amount of radioactivity to be administered for PET in an adult is 185 MBq to 259 MBq (5 mCi to 7 mCi) administered as an IV bolus injection.
Recommended dosage in pediatric patients
The recommended amount of radioactivity for pediatric patients 1 month of age and older is 3 MBq/kg actual body weight (0.081 mCi/kg) with a minimum and maximum activity of 14 MBq (0.38 mCi) and 259 MBq (7 mCi), respectively, administered as an IV bolus injection.
Fasting and hydration
Instruct patients not to eat for at least 4 hours prior to injection of Pixclara® and to ensure adequate hydration before and in the first hours after administration.
Recommended administration instructions
Use aseptic technique and radiation shielding when withdrawing and administering Pixclara®. Calculate the necessary volume to administer based on calibration time and required dose. Inspect Pixclara® visually for particulate matter and discoloration before administration. Only use solutions that are clear, colorless or slightly yellow, and without visible particles. Pixclara® may be diluted with 0.9% Sodium Chloride Injection. Assay the final dose in a dose calibrator immediately before administration to the patient. After injection of Pixclara®, administer an IV flush of 0.9% Sodium Chloride Injection to ensure full delivery of the dose. Dispose of any unused drug in a safe manner in compliance with applicable regulations.
Image acquisition
Position patient with their head in a dedicated holder and their arms resting at their sides. Use tape, padding, or other flexible head restraints to minimize head movement. Begin PET image acquisition 20 minutes to 30 minutes after Pixclara® administration. Acquire images for a single bed position centered on the brain for a duration of 20 minutes. A low dose CT or MRI scan of the brain may be used for attenuation correction.
Storage and handling1
Storage
Store Pixclara® at 15°C to 25°C (59°F to 77°F) upright in the original container with radiation shielding. Use Pixclara® within 14 hours from the time of the end of synthesis. The expiration date and time are provided on the shield container label. Dispose of any unused drug in accordance with applicable regulations.
Handling
This preparation is for use by persons under license by the Nuclear Regulatory Commission or the relevant regulatory authority of an Agreement State.
Pixclara® differentiates true tumor progression from treatment-related change.1
Learn How it WorksCT, computed tomography; IV, intravenous; MBq, megabecquerel; mCi, millicurie; PET, positron emission tomography.